1. Home
  2. GERN vs CSV Comparison

GERN vs CSV Comparison

Compare GERN & CSV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GERN
  • CSV
  • Stock Information
  • Founded
  • GERN 1990
  • CSV 1991
  • Country
  • GERN United States
  • CSV United States
  • Employees
  • GERN N/A
  • CSV N/A
  • Industry
  • GERN Biotechnology: Pharmaceutical Preparations
  • CSV Other Consumer Services
  • Sector
  • GERN Health Care
  • CSV Consumer Discretionary
  • Exchange
  • GERN Nasdaq
  • CSV Nasdaq
  • Market Cap
  • GERN 740.5M
  • CSV 670.2M
  • IPO Year
  • GERN 1996
  • CSV 1996
  • Fundamental
  • Price
  • GERN $1.12
  • CSV $41.07
  • Analyst Decision
  • GERN Buy
  • CSV Strong Buy
  • Analyst Count
  • GERN 7
  • CSV 4
  • Target Price
  • GERN $3.00
  • CSV $59.00
  • AVG Volume (30 Days)
  • GERN 8.6M
  • CSV 80.2K
  • Earning Date
  • GERN 11-05-2025
  • CSV 11-05-2025
  • Dividend Yield
  • GERN N/A
  • CSV 1.09%
  • EPS Growth
  • GERN N/A
  • CSV 38.46
  • EPS
  • GERN N/A
  • CSV 3.09
  • Revenue
  • GERN $183,403,000.00
  • CSV $409,658,000.00
  • Revenue This Year
  • GERN $166.20
  • CSV $3.97
  • Revenue Next Year
  • GERN $55.83
  • CSV $3.40
  • P/E Ratio
  • GERN N/A
  • CSV $13.37
  • Revenue Growth
  • GERN 522.13
  • CSV 1.07
  • 52 Week Low
  • GERN $1.04
  • CSV $35.51
  • 52 Week High
  • GERN $4.21
  • CSV $49.41
  • Technical
  • Relative Strength Index (RSI)
  • GERN 40.96
  • CSV 35.41
  • Support Level
  • GERN $1.04
  • CSV $40.50
  • Resistance Level
  • GERN $1.28
  • CSV $41.99
  • Average True Range (ATR)
  • GERN 0.07
  • CSV 1.20
  • MACD
  • GERN 0.00
  • CSV -0.28
  • Stochastic Oscillator
  • GERN 30.12
  • CSV 23.88

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

About CSV Carriage Services Inc.

Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise; and enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.

Share on Social Networks: